India’s antitrust body shared a February Reuters report with the court over Amazon.Com Inc’s (NASDAQ: AMZN) alleged preferential treatment to a small group of sellers on its India platform, triggering a probe into the e-commerce company, Reuters reports.
- The Competition Commission of India (CCI) launched a probe into Amazon and Walmart Inc’s (NYSE: WMT) Flipkart last year following an alleged preferential treatment complaint from a trader group. The investigation was put on hold following a court challenge from the two companies.
- Last month, Reuters’ story based on internal Amazon documents dated between 2012 and 2019 alleged Amazon’s preferential treatment to a small seller group triggered India’s Enforcement Directorate inquiry into the company.
- 35 of Amazon’s over 400,000 Indian sellers in early 2019 accounted for roughly two-thirds of its online sales based on the report. The report also reflected Amazon’s nexus in expanding an indirectly owned seller Cloudtail on its platform.
- Amazon refuted the allegations.
- CCI might seek documents from the company for examination as per a representative.
- price action: AMZN shares traded higher by 1.01% at $3,058.69 on the last check Friday.
© 2021 Fintech Zoom.com. Fintech Zoom does not provide investment advice. All rights reserved.
AMZN Stock – Amazon.com, Inc. ((NASDAQ:AMZN)), Wal-Mart Stores, Inc. ((NYSE:WMT)) – India’s Antitrust Body Uses Reuters’ Evidence In Amazon Probe: Reuters
Tags: AMZN Stock
Stock Market, Latest News on C N N.